Menec (Tibolone)

Tibolone, the active ingredient in Menec, is a synthetic steroid (progestogen/estrogen/androgen) presented as an oral tablet for oral use. It is used to alleviate menopausal symptoms and to help prevent bone loss in post‑menopausal women. GNH USA supplies Menec as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Menec (tibolone) is indicated for conditions within the hormone replacement therapy pathway, addressing menopausal and bone health concerns.

Menopausal symptoms: reduces frequency and severity of hot flashes and night sweats. Post‑menopausal osteoporosis: helps maintain bone mineral density and reduces fracture risk. Vasomotor disturbances: improves overall quality of life related to hormonal changes.

Tibolone may cause a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects: - Nausea or abdominal discomfort. - Headache or dizziness. - Breast tenderness or enlargement. - Vaginal bleeding or spotting. - Weight gain or fluid retention. - Mood changes such as irritability.

Serious or Rare Side Effects: - Deep vein thrombosis or pulmonary embolism. - Stroke or transient ischemic attack. - Liver dysfunction or jaundice. - Unexplained vaginal bleeding. - Breast cancer development. - Severe allergic reactions (rash, swelling, difficulty breathing).

Before initiating Menec, consider the following safety measures.

Contraindicated in pregnancy: avoid use in pregnant women. Breast cancer history: assess risk before prescribing. Liver disease: monitor hepatic function regularly. Cardiovascular risk: evaluate for thromboembolic disorders. Bone health monitoring: periodic bone density assessments recommended. Store at ambient temperature: keep below 25 °C, in original packaging, protected from moisture and light.

Tibolone can interact with several medications, requiring careful management.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased bleeding risk. - CYP3A4 inhibitors (e.g., ketoconazole): may raise tibolone levels. - Hormonal contraceptives: potential additive estrogenic effects.

Moderate Interactions (Monitor Closely): - Antihypertensives: possible alteration of blood pressure control. - Antidiabetic agents: monitor glucose levels. - Thyroid hormones: may affect thyroid function tests.